Epidemiology
An adipocytic sarcoma of adults that can present as a deep mass in the limb, pelvis, or chest wall. The high-grade non-fatty component must be sought, because that area guides the biopsy and the biological risk.
Basic features
It combines an atypical fatty component with a non-fatty, higher-grade area, which determines the main risk; it usually arises from an atypical lipomatous tumor / well-differentiated liposarcoma and shares the MDM2 amplification, a finding that helps confirm the diagnosis.
Usual treatment
Oncologic resection is central; radiotherapy, systemic treatment, or clinical trials are evaluated according to location and extent.
Outcomes and prognosis
It carries a risk of local recurrence and metastasis, especially if a complete resection is not achieved, with an intermediate prognosis.
